603108.SS
603108.SS
CNE100002318
SHANGHAI RUNDA MEDICAL TECHNOLO
Loading chart...

Company Profile

Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It provides laboratory design/renovation, laboratory standardization, and information management system services; various customized laboratory management solutions; professional technical services; and specialized logistic services. The company also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables. In addition, it is involved in the software development; provision of information system integration and consulting services; sale of medical devices; rental services; maintenance of electronic and mechanical equipment; import and export of technology; general cargo warehousing and road freight transportation; and wholesale of pharmaceuticals. The company was incorporated in 1999 and is headquartered in Shanghai, China.

Related stocks

300463.SZ
300463.SZ • China
MAKER BIOTECHNOLOGY
9.58 CNY
866.78M USD 1Y -17%
300406.SZ
300406.SZ • China
BSBE
12.14 CNY
1.06B USD 1Y -9.7%
300685.SZ
300685.SZ • China
AMOYDX
20.3 CNY
1.18B USD 1Y -11.6%
300244.SZ
300244.SZ • China
D.A. DIAGNOSTICS
20.4 CNY
1.91B USD 1Y +24.4%
603882.SS
603882.SS • China
GUANGZHOU KINGMED DIAGNOSTICS G
28.82 CNY
2B USD 1Y -3.4%
THYROCARE.BO
THYROCARE.BO • India
Thyrocare Technologies Limited
499 INR
820.66M USD 1Y +22%
300676.SZ
300676.SZ • China
BGI GENOMICS
45.47 CNY
2.85B USD 1Y -9.3%
4694.T
4694.T • Japan
BML INC
3,650 JPY
864.57M USD 1Y +1.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
53.1% p.a.
Max Drawdown (5Y)
-66.5%
Sharpe Ratio (5Y)
-0.09
Beta Factor
0.54
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (53.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -66.5% in the extended horizon.
ende